Compare AVTX & YQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTX | YQ |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.3M | 45.3M |
| IPO Year | 2015 | 2020 |
| Metric | AVTX | YQ |
|---|---|---|
| Price | $17.23 | $3.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $32.29 | N/A |
| AVG Volume (30 Days) | ★ 313.5K | 16.6K |
| Earning Date | 11-06-2025 | 12-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $192,000.00 | ★ $14,563,434.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.39 | $1.26 |
| 52 Week High | $20.72 | $6.45 |
| Indicator | AVTX | YQ |
|---|---|---|
| Relative Strength Index (RSI) | 43.19 | 36.35 |
| Support Level | $18.58 | $3.30 |
| Resistance Level | $18.54 | $4.58 |
| Average True Range (ATR) | 1.30 | 0.34 |
| MACD | -0.26 | -0.03 |
| Stochastic Oscillator | 1.91 | 19.31 |
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
17 Education & Technology Group Inc is an education technology company in China. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.